We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Fludarabine Followed By Adoptive Immunotherapy in Treating Patients With Stage IV Melanoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00317759
Recruitment Status : Completed
First Posted : April 25, 2006
Last Update Posted : October 1, 2015
National Cancer Institute (NCI)
Information provided by:
Fred Hutchinson Cancer Center